Menaquinone-7 (MK-7)

Category
vitamin
Routes
Oral (PO)
Half-Life (t½)
PO: 68h
Molecular Weight
649 g/mol
Aliases
Vitamin K2 MK-7, Natto-derived K2

Pharmacological Mechanism

Long 7-isoprenoid side chain → much longer plasma t½ (~68 h) than MK-4 (~1 h). Same Gla-protein carboxylation as MK-4 but steadier exposure with once-daily dosing. Produced by gut bacteria and by Bacillus subtilis natto fermentation.

Half-Life & Elimination Curve (PO: 68h)

100%50%25%12.5%0%0h0×t½68h1×t½5.7d2×t½8.5d3×t½11.3d4×t½14.2d5×t½0×t½ (0h): 100% remaining (~2.34 µg/L)1×t½ (68h): 50% remaining (~1.17 µg/L)2×t½ (5.7d): 25% remaining (~0.584 µg/L)3×t½ (8.5d): 12.5% remaining (~0.292 µg/L)4×t½ (11.3d): 6.3% remaining (~0.146 µg/L)5×t½ (14.2d): 3.1% remaining (~0.073 µg/L)
Plasma (PO)t½ Decay (68h)
  • 0×t½0h100% (2.34 µg/L)
  • 1×t½68h50% (1.17 µg/L)
  • 2×t½5.7d25% (0.584 µg/L)
  • 3×t½8.5d12.5% (0.292 µg/L)
  • 4×t½11.3d6.3% (0.146 µg/L)
  • 5×t½14.2d3.1% (0.073 µg/L)
Elimination t½68h (PO)
Rate Constant (ke)0.0102 h⁻¹
Time to Peak (Tmax)7.95h
Est. Peak (Cmax)2.34 µg/L
Clearance (CL)0.214 L/h
97% Washout (5×t½)14.2d

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Interactions

References